Thermo Fisher will be virtually presenting at the American Society on Human Genetics (Oct 27-30). These presentations are of particular interest around the theme "It's time to re-imagine healthcare together". Learn more about all our activities at ASHG this year.
MADCaP: The First Large Pan-African GWAS Tackling Cancer Health Disparities in African Populations Timothy Rebbeck, PhD Vincent L. Gregory, Jr. Professor of Cancer Prevention, Harvard TH Chan School of Public Health and Division of Population Sciences, Dana Farber Cancer Institute
How comprehensive pharmacogenomics accelerates personalized therapies and reduces health disparities for minorities Dr. Ulrich Broeckel, MD Founder and CEO, RPRD Diagnostics
Preemptive PGx at population-scale: Implementation in Pittsburgh Philip Empey, PharmD, PhD, Assoc. Director, Institute for Precision Medicine Assoc Professor, Pharmacy & Therapeutics
Implementing a world-class clinical pharmacogenomics service Dr. Hyun Kim, Clinical Pharmacist, Clinical Pharmacogenomics Service, Boston Children's Hospital
Polygenic Risk Scores - Value & Path into the Clinic
Sir Peter Donnelly (Founder, Genomic plc) & Dr. Jill Hagenkord (VP Genomics, Optum) share the stage in a presentation and panel discussion on incorporating polygenic risk scores and application in the clinic
Accurate Pharmacogenomics Testing – A Market Overview
This whitepaper summarizes the pharmacogenomics (PGx) landscape addressing regulations, global population coverage, complexity of PGx markers
Host Genetics with the new Axiom Human Genotyping SARS-CoV-2 Research Array
This webinar discusses a new whole-genome SARS-CoV-2 array to help understand how coronavirus interacts with the human genome and to stratify populations in order to understand disease susceptibility, severity, and outcomes.
Complete the short form below to obtain access to the hub.